Mitogen-activated protein kinase (MAPK) and cell division control protein 42 (Cdc42), which belong to inflammation mediated by the chemokine and cytokine signaling pathways, were detected in group C, compared with A and B. Current evidence clearly shows that MAPK pathways are viable targets for cancer therapy [33]. This evidence concerns the gene CDC42 and cancer.